Search bioRxiv⌕ Search

Biology subjects

McGregor, M. J.

Publications and source records attributed to McGregor, M. J..

4 recordsLinked to original sources

PharmCast: rapid generation of three-dimensional pharmacophore fingerprints from two-dimensional structure without conformer generation

A three-dimensional pharmacophore fingerprint records the binding features a molecule can present. It is a description of a hand in search of a glove. Because it is defined by presented features instead of two-dimensional structure, it can identify pharmacophoric similarity between structurally distinct compounds, which is what scaffold hopping and non-obvious me-too design require. The descriptor has remained a niche tool because its cost is dominated by conformer generation. In the reference pipeline, generating 100 conformers requires 2.82 s of the 2.86 s needed to fingerprint one screening collection compound; the bit calculation requires 0.039 s. We therefore removed the conformational stage. PharmCast is a feedforward neural network that predicts all 10,549 bits of a PharmPrint ensemble fingerprint directly from a SMILES string. On the same machine, PharmCast generated pharmacophore fingerprints for two molecules and compared them in 0.584 ms, whereas the conventional conformer-based pipeline took 5.71 s. PharmCast version 10 was trained on 5,887,229 molecules drawn from a screening collection, activity-backed ChEMBL compounds from 142 to 1000 Da, and peptide loops excised from crystal structures. We evaluated 155,648 purchasable catalog compounds excluded from every training set, 139,700 activity-backed ChEMBL compounds not present in the version 10 training set, and 13,500 peptide loops reserved for testing. Median fingerprint error, Pearson r, and pairwise ranking accuracy were 0.008, 0.980, and 0.936 for screening collection chemistry; 0.016, 0.984, and 0.952 for loop peptides; and 0.027, 0.936, and 0.889 for activity-backed ChEMBL compounds. The reference calculation reproduces itself at an error of 0.006 and r of 0.995. Ensemble pharmacophore fingerprints can therefore be predicted from two-dimensional structure alone at a cost suitable for large-scale collection screening and virtual library exploration. Keywords: pharmacophore, fingerprint, scaffold hopping, surrogate model, virtual screening, applicability domain

bioinformatics↗

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption1,2. There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 66 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays. The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.

systems biology↗

Efficient Generation of Isogenic Primary Human Myeloid Cells using CRISPR-Cas9 Ribonucleoproteins

Genome engineering of primary human cells with CRISPR-Cas9 has revolutionized experimental and therapeutic approaches to cell biology, but human myeloid-lineage cells have remained largely genetically intractable. We present a method for delivery of CRISPR-Cas9 ribonucleoprotein (RNP) complexes by nucleofection directly into CD14+ human monocytes purified from peripheral blood, leading to high rates of precise gene knockout. These cells can be efficiently differentiated into monocyte-derived macrophages or dendritic cells. This process yields genetically-edited cells that retain critical markers of both myeloid differentiation and phagocytic function. Genetic ablation of the restriction factor SAMHD1 increased HIV-1 infection more than fifty-fold, demonstrating the power of this system for genotype-phenotype interrogation. This fast, flexible and scalable platform can be used for genetic studies of human myeloid cells in immune signaling, inflammation, cancer immunology, host-pathogen interactions, and beyond, and could facilitate development of novel myeloid cellular therapies.

genetics↗

A CRISPR-Cas9 Genome Engineering Platform in Primary CD4+ T Cells for the Interrogation of HIV Host Factors

CRISPR-Cas9 gene editing strategies have revolutionized our ability to engineer the human genome for robust functional interrogation of complex biological processes. We have recently adapted this technology to primary human T cells to generate a high-throughput platform for analyzing the role of host factors in pathogen infection and lifecycle. Here, we describe applications of this system to investigate HIV pathogenesis in CD4+ T cells. Briefly, CRISPR-Cas9 ribonucleoproteins (crRNPs) are synthesized in vitro and delivered to activated primary human CD4+ T cells by nucleofection. These edited cells are then validated and expanded for use in downstream cellular, genetic, or protein-based assays. Our platform supports the arrayed generation of several gene manipulations in only a few hours time and is widely adaptable across culture conditions, infection protocols, and downstream applications. We present detailed protocols for crRNP synthesis, primary T cell culture, 96-well nucleofection, molecular validation, and HIV infection with additional considerations for guide and screen design as well as crRNP multiplexing.

systems biology↗